Petersen Rebecca Ann has filed 3 insider transactions across 1 company since August 2025.
Most recent transaction: a option exercise of 24834 shares of CapsoVision, Inc ($CV) on August 18, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 18, 2025 | CapsoVision, Inc | $CV | Petersen Rebecca Ann | Director of Clinical Affairs | M | Common Stock | 24834 | $0.37 | 24,834.0000 | 0 | 9999.99% | 0.00% |
| Aug. 18, 2025 | CapsoVision, Inc | $CV | Petersen Rebecca Ann | Director of Clinical Affairs | M | Stock Option (right to buy) | 7507 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 18, 2025 | CapsoVision, Inc | $CV | Petersen Rebecca Ann | Director of Clinical Affairs | M | Stock Option (right to buy) | 17327 | $0.00 | 3,694.0000 | 0 | 82.43% | 0.00% |